Trained immunity alleviates the progression of melanoma during sepsis-associated immunoparalysis
Cellular Oncology · 2025
DOI: 10.1007/s13402-025-01063-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, 2025. Verfasst von Lijie Yin und 7 weiteren Autor:innen. Beteiligte Einrichtung: The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, Nanjing, 210093, China. Hauptthemen laut MEDLINE: Sepsis, Melanoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Natural Science Foundation of China, the National Key R&D Program of China, Nanjing Medical Science and Technique Development Foundation.
Themen: Sepsis
Abstract (Originalsprache)
BACKGROUND: Patients who survive the excessive inflammatory phase of sepsis experience prolonged immunoparalysis/immunosuppression. During this phase, the patient's immune system is severely impaired, which increases the patient's susceptibility to septic complications. Sepsis survivors have a significantly greater incidence of cancer, but the mechanism underlying this phenomenon is unknown. METHODS: We constructed two sepsis-melanoma models to assess the relationship between sepsis and sepsis-related concomitant cancer. In our investigation, we employed a range of experimental technique to elucidate the intricate mechanisms through which the immunoparalysis phase of sepsis facilitates melanoma progression. Furthermore, we induced trained immunity with oroxylin A (OA) to evaluate its ability to reverse immunoparalysis and subsequent tumor progression in sepsis-melanoma models. RESULTS: We showed that sepsis upregulated the serum level of interleukin (IL)-6 and the number of myeloid-derived suppressor cells (MDSCs), regulated G-MDSCs/M-MDSCs and inhibited CD8+T-cell function, which promoted melanoma progression. OA-induced trained immunity can reverse immunoparalysis, maintain the antitumor capacity of the immune system, and inhibit the development of sepsis-complicated melanoma. Notably, OA can target macrophage migration inhibitory factor (MIF) and downregulate the serum level of IL-6, which may be a crucial molecular mechanism by which OA induces trained immunity to reverse the immunoparalysis phase of sepsis. CONCLUSION: Sepsis can promote cancer progression by upregulating MIF and IL-6, increasing the G-MDSCs/M-MDSCs ratio and reducing the number and function of CD8+ T cells, leading to immunoparalysis, while trained immunity can alleviate this progression. The findings of this study provide new strategies for preventing or treating sepsis-complicated cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, Nanjing, 210093, China.
- The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, Nanjing, 210093, China. douhuan@nju.edu.cn.
- Jiangsu Key Laboratory of Molecular Medicine, Nanjing, 210093, China. douhuan@nju.edu.cn.
- Department of Obstetrics and Gynecology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China. zhaoguangfeng@nju.edu.cn.
- The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, Nanjing, 210093, China. yayihou@nju.edu.cn.
- Jiangsu Key Laboratory of Molecular Medicine, Nanjing, 210093, China. yayihou@nju.edu.cn.
Förderung
- National Key Natural Science Foundation of China
- the National Key R&D Program of China
- Nanjing Medical Science and Technique Development Foundation
Zitieren
APA
Yin, L., Dong, Y., Luo, R., Li, J., Wang, J., Dou, H., Zhao, G., & Hou, Y. (2025). Trained immunity alleviates the progression of melanoma during sepsis-associated immunoparalysis. Cellular Oncology. https://doi.org/10.1007/s13402-025-01063-8
Vancouver
Yin L, Dong Y, Luo R, Li J, Wang J, Dou H, et al. Trained immunity alleviates the progression of melanoma during sepsis-associated immunoparalysis. Cellular Oncology. 2025. doi:10.1007/s13402-025-01063-8
BibTeX
@article{Yin2025,
author = {Yin, Lijie and Dong, Yue and Luo, Renjie and Li, Jingman and Wang, Jiali and Dou, Huan and Zhao, Guangfeng and Hou, Yayi},
title = {Trained immunity alleviates the progression of melanoma during sepsis-associated immunoparalysis},
journal = {Cellular Oncology},
year = {2025},
doi = {10.1007/s13402-025-01063-8}
}
EUVIMED